Therapeutic Options in IgG4-Related Disease
Sign Up to like & getrecommendations! Published in 2020 at "Current Treatment Options in Rheumatology"
DOI: 10.1007/s40674-020-00147-w
Abstract: Purpose of review IgG4-related disease (IgG4-RD) is an autoimmune fibrosing condition which is being increasingly recognized. This condition has been classically managed with glucocorticoids (GC) with variable dosing and frequent relapses. Multiple observational reports studied… read more here.
Keywords: related disease; steroid sparing; treatment; sparing agents ... See more keywords
Stopping oral steroid-sparing agents at initiation of rituximab in myasthenia gravis
Sign Up to like & getrecommendations! Published in 2019 at "Neuromuscular Disorders"
DOI: 10.1016/j.nmd.2019.06.002
Abstract: Rituximab is a chimeric monoclonal antibody that binds CD20 and causes the depletion of B-cell subsets. Although initially designed to treat lymphoma, it has found wide use in the management of various autoimmune conditions, including… read more here.
Keywords: agents initiation; stopping oral; steroid sparing; oral steroid ... See more keywords